Background/Objectives: Dementia and cognitive impairment are common in nursing homes. Few studies have studied the impact of unnoted cognitive impairment on medical care. This study aimed to estimate the prevalence of diagnostic failure of cognitive impairment in a sample of Swedish nursing home residents and to analyze whether diagnostic failure was associated with impaired medical care. Method: A total of 428 nursing home residents were investigated during 2008-2011. Subjects without dementia diagnosis were grouped by result of the Mini Mental State Examination (MMSE), where subjects with < 24 points formed a possible dementia group and the remaining subjects a control group. A third group consisted of subjects with diagnosed dementia. These three groups were compared according to baseline data, laboratory findings, drug use, and mortality. Results: Dementia was previously diagnosed in 181 subjects (42%). Among subjects without a dementia diagnosis, 72% were cognitively impaired with possible dementia (MMSE < 24). These subjects were significantly older, did not get anti-dementia treatment, and had higher levels of brain natriuretic peptide compared to the diagnosed dementia group, but the risks of malnutrition and pressure ulcers were similar to the dementia group. Conclusions: Unnoted cognitive impairment is common in nursing home residents and may conceal other potentially treatable conditions such as heart failure. The results highlight a need to pay increased attention to cognitive impairment among nursing home residents.
Introduction
Cognitive decline is highly prevalent in old age and constitutes a major predictor for long-term care use [1] . The estimated frequency of dementia or cognitive impairment in long-term care populations varies between studies in different countries. A systematic review reports a median prevalence of 58%, but with a considerable variation in prevalence (12-95%) as well as in sample sizes and diagnostic instruments [2] . A report from the EU Commission estimates that approximately 80% of patients in long-term care suffer from cognitive decline or a diagnosed progressive memory disorder [1] . A study performed at nursing homes in 7 European countries and Israel reports a 70% prevalence of cognitive decline [3] .
The Swedish National Board of Health and Welfare has estimated that 70% of residents in Swedish nursing homes may suffer from dementia [4] . A recent study in a Swedish sample of nursing homes found cognitive impairment in 67% [5] , but with cognitive assessment performed through a questionnaire sent to the nursing home staff and not a cognitive test. In a recent Norwegian study, cognitive investigation on admission to nursing homes found dementia in 84% [6] . However, dementia is generally underdiagnosed, exemplified by nursing home studies in Scotland [7] and Austria [8] that found cognitive impairment in a total of 90 and 85% respectively, of which about one third was previously unknown. Moreover, a recent review reports a high proportion of undetected dementia not only in nursing homes, but in community-dwelling older people as well [9] . Undiagnosed dementia means a lack of antidementia drug treatment, less awareness of possible inappropriate drugs, and inferior interaction and understanding between residents and caregivers, and has prognostic implications [10] .
Few studies have studied the impact of unnoted cognitive impairment on medical care in other aspects. One study found that pain was more prevalent among cognitively impaired nursing home residents with dependency in activities of daily living [5] , but another study found that residents without dementia had more pain than patients with dementia [6] . Previous community-based studies have shown a negative association between cognitive function and levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is used as a marker of heart failure in clinical practice [11] [12] [13] . Furthermore, dementia and cognitive impairment are related to an increased risk of malnutrition [14] . B-type natriuretic peptide (BNP) is a hormone produced mainly by ventricular cardiomyocytes and with secretion associated with stretching of myocardial fibers. BNP has previously been shown to be useful in confirming a heart failure diagnosis, guiding treatment, and providing a prognosis. The sensitivity for heart failure due to systolic dysfunction is high (93-97%), but as the specificity is somewhat lower (84%) an echocardiography is recommended to confirm a heart failure diagnosis [15, 16] . There is no difference between the diagnostic accuracy of BNP and NT-proBNP [15] .
Life expectancy in Sweden is among the highest in the European Union [17] . Due to an increasing proportion of older people and a decreasing number of nursing home beds, the proportion of elderly people living in nursing homes is decreasing [18] . A similar development in Norway has been shown to lead to a higher proportion of cognitively impaired elderly nursing home residents [19] . Consequently, increased knowledge about cognitively impaired older people in nursing homes is essential.
This study aimed to estimate the prevalence of diagnostic failure of cognitive impairment in a sample of Swedish nursing home residents and to investigate whether diagnostic failure of cognitive impairment was associated with impaired medical care.
Study Population
The Study of Health and Drugs in the Elderly (SHADES) was a longitudinal cohort study that included older people living in 12 nursing homes in three different areas in the southern part of Sweden (Jönköping, Linköping and Eslöv) [20] during 2008-2011.
All residents living in nursing homes on a permanent basis were invited to participate, whereas temporary residents were excluded as well as persons with language difficulties or under the age of 65 years. When a resident moved or died, the next person who moved in was invited to participate. A total of 428 study subjects were included.
Methods of Investigation
Study subjects were examined at baseline by specially trained study nurses who also collected data from patient records on diagnoses and drug use. Diagnoses were collected with diagnosis codes according to the Swedish version of the International Classification of Diseases (ICD) -10th version [21] . Dementia was defined as any of the ICD codes, i.e., F00 dementia in Alzheimer's disease, F01 vascular dementia, F02 dementia in other diseases classified elsewhere, F03 unspecified dementia, or G30 Alzheimer's disease.
Drugs prescribed for continuous use on the day of data collection were registered with codes according to the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system [22] . The number of regularly used drugs and of psychotropic drugs, defined as antipsychotics (ATC code N05A), anxiolytics (N05B), sedatives (N05C), and antidepressants (N06A), was calculated for each subject. Drugs taken as needed were not registered. Usage of cardiovascular and psychotropic drugs and substitution with cobalamin and folate in the groups were compared.
The in-person testing of study subjects was performed by the specially trained study nurses with assistance from the nursing home staff, and included measurements of weight, height, pulse, and blood pressure. Blood pressure was measured three times at 1-min intervals in the right arm, while in a sitting position, and the mean value of the three measurements was used.
A standardized Swedish version of the Mini Mental State Examination (MMSE) [23] , performed by the specially trained study nurses, was used to measure cognitive function. The scores range from 0 to 30, with a score below 24 indicating cognitive dysfunction. MMSE could not be performed on all participants, due to reasons such as severe aphasia, refusal, blindness or impaired hearing.
Three groups of study subjects based on dementia diagnosis and cognitive function were compared. One group consisted of subjects with diagnosed dementia. Subjects without dementia diagnosis were grouped by result of the MMSE, where subjects with an MMSE score ≥24 formed a control group and subjects with an MMSE score < 24 formed a group with undiagnosed cognitive impairment, subsequently named a "possible dementia group." Due to missing MMSE results, 28 study subjects without a dementia diagnosis were excluded. These subjects were not considered to differ from the study subjects in general according to answers from staff about their cognitive function.
The number of study subjects included, excluded or missing and the control groups are illustrated in Figure 1 .
Risk assessments based on interviews performed by the study nurses with the nursing home staff were performed. The modified Norton scale [24] was used to assess the risk of developing pressure ulcers, and the short-form Mini-Nutritional Assessment [25] to assess the risk of malnutrition.
A questionnaire previously used by the Swedish National Study of Aging and Care [26] was performed, with 25 questions from the study nurses to the nursing home staff concerning activities of daily living, need for care, different symptoms, and mood. The Cornell Scale for Depression in Dementia, in this study based solely on information from staff members, was used to measure depressive symptoms [27] .
Blood samples were drawn according to a standard procedure. Hemoglobin was analyzed at local laboratories and remaining blood samples were stored at −70 ° C in a freezer and analyzed at the laboratory at the County Hospital Ryhov in Jönköping by high-pressure liquid chromatography. Several blood analyses were performed in order to compare the health status between the groups. To assess renal function, we used the formula for estimating the glomerular filtration rate according to updated Swedish guidelines [28] . BNP, previously shown to have a close correlation with NT-proBNP [29] , was analyzed. For BNP measurements, a cutoff value of 100 ng/L has been previously suggested to indicate heart failure [30] . For survival calculations, mortality dates were collected from the Swedish population register.
Statistical Analysis
All statistical analyses were performed using SPSS Statistics version 24 (SPSS, Inc. Chicago, IL, USA). Descriptive statistics were used for baseline characteristics. For comparison of baseline characteristics between the three groups, one-way ANOVA was used for continuous variables when the mean values were assumed to be normally distributed, Kruskal-Wallis was used for continuous variables with considerable skewness, and the two-sided Pearson's χ 2 test was used for discrete variables. A p value of < 0.05 was considered statistically significant.
To compare prevalence of drug classes and general symptoms in the three groups, the two-sided Pearson's χ 2 test was used. When the groups were small, Fischer's test was used. To avoid mass significance in these analyses, p values < 0.01 were considered statistically significant and p values < 0.05 but ≥0.01 were considered as nonsignificant tendencies. A Cox regression analysis with a survival plot of the three groups with adjustment for age and sex was created for survival calculations.
Results
This study included 400 study subjects ( Fig. 1 ) with a mean age of 85 years (range 65-101 years) of whom 234 (71%) were women. 181 subjects had a dementia diagnosis. Among those assessed with the MMSE without diagnosed dementia, 157 subjects had an MMSE score < 24 suggesting possible dementia and 62 subjects had an MMSE score ≥24 and formed the control group. Baseline characteristics of the study population and the three control groups are presented in Table 1 . The groups differed significantly in age, weight, height, and number of medications. The possible dementia group was significantly older than the diagnosed dementia group, but otherwise these two groups did not differ significantly in any other general characteristics (Table 1) .
Blood analyses showed significantly higher BNP levels in the possible dementia group compared to the diagnosed dementia group. When we analyzed the proportion of subjects with high BNP levels (≥100 ng/L), there was a significantly higher proportion of high values in the group with possible dementia compared to the group with diagnosed dementia, which remained when subjects with known heart failure were excluded (Table 1) . The proportion of subjects on substitution with cobalamin and folate differed significantly between the three groups ( Table 2) . When subjects on substitution were excluded, there were no significant differences in mean serum cobalamin or folate levels or prevalence of low values between the three groups (Table 1) .
Polypharmacy was more common in the control group than in the other two groups. The possible dementia group was rarely treated with anti-dementia drugs (acetylcholinesterase 1 One-way ANOVA, 2 χ 2 test, 3 Kruskal-Wallis test; significant differences between groups in post hoc tests: a diagnosed dementia versus control group, b possible dementia versus control group, c diagnosed dementia versus possible dementia. inhibitors or memantine, Table 2 ). More subjects in the control group than in the diagnosed dementia group were treated with hypnosedatives ( Table 2 ).
There were more subjects on therapy with diuretics and less substitution with cobalamin and folate in the possible dementia group compared to the diagnosed dementia group ( Table 2) .
The risks of malnutrition and pressure ulcers were similar in the diagnosed dementia group and the possible dementia group and were significantly higher than in the control group. Figure 2 shows survival curves for the three groups adjusted for age and sex. The differences in mortality between the groups were not significant.
Discussion/Conclusion
This study found differences of clinical importance between the cognitively impaired group with possible dementia (MMSE < 24) and the diagnosed dementia group. Higher occurrence of elevated BNP levels in the possible dementia group may indicate undertreated heart failure, which is known to be associated with cognitive impairment [31] and dementia [32] . Previously published data from SHADES showed a tendency towards higher cognitive function in subjects with established heart failure diagnosis compared to subjects without diagnosed heart failure [33] . A reason for this, also suggested by a recent Norwegian nursing home study [34] , may be that generally less attention is paid to physical symptoms of subjects with cognitive impairment, which may cause undiagnosed physical disease. Furthermore, differences in cardiovascular drug treatment between the groups may reflect undiagnosed heart failure ( Table 2 ). More diuretic use in the possible dementia group than in the dementia group may reflect symptomatic treatment of undiagnosed heart failure. The control group, without cognitive impairment and possibly with more somatic illness, uses the same amount of diuretics but also has a tendency to use more beta blockers.
BNP levels can be influenced by renal function and age [35] . However, age differences in the present study, though significant, were not considered to influence BNP differences more than marginally, and there were no differences in renal function as measured by the glomerular filtration rate ( Table 1) .
The age differences indicate that age might affect the amount of attention paid to cognitive impairment. Few subjects in the possible dementia group were on treatment with anti-dementia drugs, which presumably confirms that no dementia investigation was performed. Furthermore, substitution with cobalamin and folate were more common in the diagnosed dementia group (Table 2) , possibly due to an established practice of starting substitution with these vitamins at levels below or in the lower normal area in connection with performing a dementia investigation. However, there were no differences in serum cobalamin or folate levels among individuals without substitution ( Table 2 ). For subjects with diagnosed dementia, cognitive deficits may have constituted the main reason for moving into a nursing home, indicated by younger age and less cardiovascular medication in this group. For those without a dementia diagnosis, more complex comorbidity may have contributed but may have been overlooked. More subjects in the control group than in the dementia group were treated with hypnosedatives, a difference that was due to more frequent use of nonbenzodiazepine hypnotics in the control group.
Overall, the possible dementia group showed several similarities with the dementia group such as high risk of malnutrition and pressure ulcers ( Table 2 ) and a similar mortality rate. However, neither survival curves (Fig. 2) Color version available online differed significantly between the groups. Earlier studies have described that considerable proportions of nursing home residents have cognitive impairment but no dementia diagnosis [6] [7] [8] . We found cognitive impairment in 72% of those without dementia assessed with the MMSE. As MMSEs were missing for 28 subjects, we estimate that 177 subjects in the original sample of 428 may have undiagnosed dementia compared to 181 with a dementia diagnosis. This means that up to 84% were cognitively impaired, which is on a level with previous studies with a similar approach [6] [7] [8] 34] , but only half of them had a known dementia diagnosis. Furthermore, we believe that an MMSE cutoff of < 24 is a conservative (and underestimating) MMSE value for cognitive impairment, considering that a recent study suggests an MMSE cutoff of ≤26 for older persons up to the age of 93 [36] . Studies in the field are generally difficult to compare because there are differences in diagnostic tools and underlying populations, as previous reviews have pointed out [2, 9] . MMSE is not a diagnostic tool but a screening instrument suggesting cognitive impairment, and a limitation in this study is the lack of proper diagnostic evaluation of the group with cognitive impairment named "possible dementia." There is a possible selection bias in SHADES as the participating nursing homes were chosen by convenience and nursing homes showing interest were selected. However, the inclusion of nursing homes from three different municipalities increases the chance that they were representative of Sweden. Another limitation is that the data were collected in the period 2008-2011, and the health status of older people living in nursing homes and "traditions" in drug use may have changed during the last few years. However, the total prevalence of cognitive decline in this study is in line with later collected data [6] .
In conclusion, unnoted cognitive impairment in nursing home residents is common and may indicate other potentially treatable conditions such as heart failure. Undiagnosed cognitive impairment shows several similarities with diagnosed dementia such as a high risk of malnutrition and pressure ulcers and a similar mortality rate. In clinical practice, these findings highlight the need to pay increased attention to signs of cognitive impairment in nursing home residents.
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